Today's Veterinary Practice

JAN-FEB 2018

Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.

Issue link: https://todaysveterinarypractice.epubxp.com/i/919967

Contents of this Issue

Navigation

Page 28 of 101

of dog owners agree that their pets should have 12 months of flea and tick protection 7 The average dog owner applies approximately 4.6 monthly flea treatments in a year. 8 Pet owners prefer BRAVECTO ® 9 to 1 over monthly treatments 9 Ask your Merck Animal Health Rep about BRAVECTO ® or visit Bravectovets.com 1 BRAVECTO ® Chew for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2014. 2 BRAVECTO ® Topical Solution for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 3 BRAVECTO ® Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 4 Rohdich N et al. Parasites & Vectors. 2014;7:83. 5 Freedom of Information Summary, NADA 141-426. Approved May 15, 2014. 6 Freedom of Information Summary, NADA 141-459. Approved 2016. 7 Lavan et al. P&V. 2017; 10:284. 8 Brakke Consulting US Flea Control & Heartworm Markets report; 2015. 9 Lavan et al. J Vet Sci Technol. 2017; 8:439. * BRAVECTO ® kills fleas and prevents flea infestations for 12 weeks. BRAVECTO ® Chew and BRAVECTO ® Topical Solution for Dogs kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kills lone star ticks for 8 weeks. BRAVECTO ® Topical Solution for Cats kills ticks (black-legged tick) for 12 weeks and American dog ticks for 8 weeks. IMPORTANT SAFETY INFORMATION: BRAVECTO ® has not been shown to be effective for 12-weeks' duration in puppies or kittens less than 6 months of age. BRAVECTO ® Chew and BRAVECTO ® Topical Solution for Dogs: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO ® is not effective against lone star ticks beyond 8 weeks of dosing. BRAVECTO ® Topical Solution for Cats: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO ® is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of BRAVECTO ® has not been established in breeding, pregnant and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving BRAVECTO ® , even in cats without a history of neurologic abnormalities. Copyright © 2018 Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc. All rights reserved. US/BRV/1117/0105 ¨ BRAVECTO ® can help close the compliance gap Veterinarians recommend year-round flea and tick protection What do dog owners think? 62% of dog owners remembered their veterinarian's exact recommendation 7 73% Is everyone following the 12-month recommendation? No. See full Prescribing Information on page 2.

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Practice - JAN-FEB 2018